US Center for Disease Control and Prevention says Democratic Republic of the Congo will run out of Ebola vaccine
Robert Redfield, director of the Center for Disease Control and Prevention (CDC), testified at a hearing before the US House of Representatives that the Democratic Republic of the Congo (DRC) will exhaust the current supply of the Ebola vaccine before the manufacturing of new vaccines can be completed.
Merck, the vaccine producer, closed the US facility that had produced the first vaccine lot and has moved its production to Germany, where plans for producing the vaccine are awaiting approval. Approval for additional resources from the US are also being held up by the Trump Administration's strict interpretation of the Trafficking Victims Protection Act. Redfield predicts that the delay in vaccine production may result in a waiting period of six to twelve months before there is an adequate supply.